EnhancerAtlas 2.0: an updated resource with typical enhancer annotation in 600 tissue/cell types across nine species
EnhancerAtlas 2.0
TagContent
EnhancerAtlas ID
HS088-12446 
Organism
Homo sapiens 
Tissue/cell
HeLa-S3 
Coordinate
chr12:26076710-26078740 
Target genes
Number: 2             
NameEnsembl ID
TF binding sites/motifs
Number: 34             
TFJASPAR IDCoordinateMotif SequenceStrand-Log10(p-value)
EWSR1-FLI1MA0149.1chr12:26078526-26078544GGAAGGAAGGAAGGAAGG+10.83
EWSR1-FLI1MA0149.1chr12:26078530-26078548GGAAGGAAGGAAGGAAGG+10.83
EWSR1-FLI1MA0149.1chr12:26078534-26078552GGAAGGAAGGAAGGAAGG+10.83
EWSR1-FLI1MA0149.1chr12:26078538-26078556GGAAGGAAGGAAGGAAGG+10.83
EWSR1-FLI1MA0149.1chr12:26078542-26078560GGAAGGAAGGAAGGAAGG+10.83
EWSR1-FLI1MA0149.1chr12:26078546-26078564GGAAGGAAGGAAGGAAGG+10.83
EWSR1-FLI1MA0149.1chr12:26078550-26078568GGAAGGAAGGAAGGAAGG+10.83
EWSR1-FLI1MA0149.1chr12:26078554-26078572GGAAGGAAGGAAGGAAGG+10.83
EWSR1-FLI1MA0149.1chr12:26078558-26078576GGAAGGAAGGAAGGAAGG+10.83
EWSR1-FLI1MA0149.1chr12:26078562-26078580GGAAGGAAGGAAGGAAGG+10.83
EWSR1-FLI1MA0149.1chr12:26078566-26078584GGAAGGAAGGAAGGAAGG+10.83
EWSR1-FLI1MA0149.1chr12:26078570-26078588GGAAGGAAGGAAGGAAGG+10.83
EWSR1-FLI1MA0149.1chr12:26078518-26078536AGAAAAAAGGAAGGAAGG+6.84
EWSR1-FLI1MA0149.1chr12:26078574-26078592GGAAGGAAGGAAGGACAA+7.54
EWSR1-FLI1MA0149.1chr12:26078522-26078540AAAAGGAAGGAAGGAAGG+7.95
Foxd3MA0041.1chr12:26076731-26076743GTTTGTTTGTTT+6.32
Foxd3MA0041.1chr12:26076735-26076747GTTTGTTTGTTT+6.32
Foxd3MA0041.1chr12:26076739-26076751GTTTGTTTGTTT+6.32
Foxd3MA0041.1chr12:26076743-26076755GTTTGTTTGTTT+6.32
Nkx2-5(var.2)MA0503.1chr12:26077305-26077316AAGCACTCAAG+6.02
SPI1MA0080.4chr12:26078142-26078156AAAAAGAGGAAGCA+6.41
SPICMA0687.1chr12:26078142-26078156AAAAAGAGGAAGCA+6.59
ZNF263MA0528.1chr12:26078523-26078544AAAGGAAGGAAGGAAGGAAGG+6.16
ZNF263MA0528.1chr12:26078527-26078548GAAGGAAGGAAGGAAGGAAGG+6.94
ZNF263MA0528.1chr12:26078531-26078552GAAGGAAGGAAGGAAGGAAGG+6.94
ZNF263MA0528.1chr12:26078535-26078556GAAGGAAGGAAGGAAGGAAGG+6.94
ZNF263MA0528.1chr12:26078539-26078560GAAGGAAGGAAGGAAGGAAGG+6.94
ZNF263MA0528.1chr12:26078543-26078564GAAGGAAGGAAGGAAGGAAGG+6.94
ZNF263MA0528.1chr12:26078547-26078568GAAGGAAGGAAGGAAGGAAGG+6.94
ZNF263MA0528.1chr12:26078551-26078572GAAGGAAGGAAGGAAGGAAGG+6.94
ZNF263MA0528.1chr12:26078555-26078576GAAGGAAGGAAGGAAGGAAGG+6.94
ZNF263MA0528.1chr12:26078559-26078580GAAGGAAGGAAGGAAGGAAGG+6.94
ZNF263MA0528.1chr12:26078563-26078584GAAGGAAGGAAGGAAGGAAGG+6.94
ZNF263MA0528.1chr12:26078567-26078588GAAGGAAGGAAGGAAGGAAGG+6.94
Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder
Number of disease enhancers: 1             
ChromosomeStartEnd
chr122607700026078408
Number: 1             
IDChromosomeStartEnd
GH12I025923chr122607690126078424
Enhancer Sequence
ACTAGAATTT TTCGAGGTTT TGTTTGTTTG TTTGTTTGTT TGTTTGAGAC AGGGCCTTGC 60
TCTGTTGCCC AGGCTGGAAT GCAGTGGCAT GATCTCAGCT CACTGCAGCC TCGACTTCCT 120
GGGACCAAGC AATCCTTCCA ACTCAGCCTC CTAAGTAGCT AGGACTACAG GCATGCACCA 180
TCACGCCCAG CTAATTTTGT TTTTTGTAGG TATGAGGTCT CACTCTTGCC CAGGCTGGTC 240
TCAAACTTCT GGACTCAAGC AATCCTTCTG TCAAAAGCCT CCCAAAGTGT TGGGATTGCA 300
GGCGTGAGCT ACCATGATGG CCTCTTTGAG TAGCATTTTT TTTTTTAGAA ATGTGAAGGT 360
TCTAGGACTT CTGGTGCTTC AGTCAATTCA ACCATTTTCT TGCTATTTCT CCCGTACCCA 420
TCTTCATCCA CTCTTATTCA CTGAGCTCCT GGGCATCTTC TGGTTCATCT TCTGCGTTCT 480
TGGCAAAGAA TATCAGAATT CAAACATTTT TCCTTAAACT ATAATAACAG CAACCAAAGC 540
CCACTATAAA TGTAAAACTT CATCTGTTGG GATAAAATCT TTAGAACTAA ATATAAAGCA 600
CTCAAGAAGC AGCAGTAGTT AATGGTATGT AATTAAAATA TCAACTTTAA AATGTACCTC 660
CGGGGACATT TTAACAAAGT CCAATTTAAA GAATTTTCAC TGTGCCAAGG AGGTGTTCTA 720
TTGAGCCTTA GTAGATTGAA AAATCAACTG CTGAGATCTC GCCATGAGGT AAGCCTGCTC 780
TGCATGCCAT TGTAAGTGGA AGTCCTGGAG CAAAATCCAG CACTGTCACG GCAGGCCTGC 840
AGGAGACTGC AGAGGCTCTC AACTTCTATG GGGCCAGGAG CACAAACCTT TGATGATGGG 900
ATGCGTTGGG ACTCACGGCT GGACAGCAGG CTAGACCAGG GGAAATATTA GCCTGACTAC 960
ACATCCTGTT TAAACAGAAG GGTTCTGCTC TATCATTTCC TTTTTCCTTT CATGAATGTG 1020
TCCAAATGCC AATTTAAGCC ATGTTCCTAA GAAATAAACT AACAGACATC AGTATATAGA 1080
AAATGAAAAC TAGTCATTAT GCCCTCTGGC TACAAAATAT TCACAATTAA AGAGGAAGCA 1140
TAGGCCAGGC ACGGTGACTC ACGCCTGTAA TCCCAAAACT TTACGAGGCT GAGGCTGGTG 1200
GATCACCTGA GGTCAGGAGT TTGAGATCAG CCTGGCGAAC ATGGTGAAAC CCTGTCTCTA 1260
CTAAGAATAC AAAAATTAGC TGGGTGTGGT GGGGCGTGCC TGTAATCCCA GCTACTTGGG 1320
AAACCGAGGC AAGAGAATCG CTTGAACCCA GGAGGCGAAA GTTGCAGTGA GCCCAGATTG 1380
CACCATTGCA CTCCAGCCTG GGTGACATAG TGAGACTCCG TCTCAAAAAA AAAAAAAGAG 1440
GAAGCATACT GAGAAGCCAT ATATAAAATG TAGACCATTC AGCCTCTACT TGGGACATCG 1500
ACCCAGCCAC CAGCCAGGCC CATTTCCAAT GTTCAATCTT GCTAGCAATG AACACTTGTT 1560
GAGTACCAGC TAGTCAAGTT ACCATGCTAC TGAGACAGTA TGTGGTTCTT TCATCCGCAT 1620
CTTCCTGGTA AAGAATTCTC ACTTTTTAAA ATACCATTCC CAGCTGGGCA CAGTGGTTCA 1680
CACTTGTAAT CTCAACATTT TGGAAGGCTG AAGTAGGAGG ACTGCTTGAG CCTCGGAGGT 1740
CAAGGCTACA ATGAGCCAAG ATCGTGCCAG TGCACTACAG CCTAGGTAAC AGAGTGAGAC 1800
TCTGTCTCAG AAAAAAGGAA GGAAGGAAGG AAGGAAGGAA GGAAGGAAGG AAGGAAGGAA 1860
GGAAGGAAGG AAGGAAGGAC AAAAGAAGAA ATTTTAAAAA TAAAACATAA AATAGGCCAG 1920
GTGCGGTGGC TCACGCCTGT AATCTCAGCA ATTTGGGAGA CCGAGGCAGG CAGATTACTT 1980
GAAGTCAGGA GTTCCAGACT AGCCTGGCCA ACATGGTGAA ATCCCATCTG 2030